Literature DB >> 18552533

[Long-term results of total hip arthroplasty in patients with juvenile rheumatoid arthritis].

Nafiz Bilsel1, Alper Gökçe, Hayrettin Kesmezacar, Erhan Mumcuoğlu, Huri Ozdoğan.   

Abstract

OBJECTIVES: We evaluated the long-term results of total hip arthroplasty (THA) in patients with juvenile rheumatoid arthritis (JRA).
METHODS: The study included 37 hips of 23 patients (22 females, 1 male; mean age 22 years; range 17 to 30 years) who underwent THA for hip degeneration secondary to JRA. All arthroplasties were performed through an anterolateral approach by the same senior surgeon. The mean body surface of the patients was 1.5 m2 (range 1.1 to 1.7 m2) and the mean symptom duration to surgery was 12 years (range 7 to 16 years). Twenty-three hips received cemented, 14 hips received hybrid prostheses. In seven hips with an extremely narrow femoral medulla and shallow acetabulum, a CDH prosthesis was used. The hips were evaluated using the Harris hip score. Prosthetic loosening and displacement and heterotopic bone formation were assessed on follow-up radiographs. The mean follow-up period was 135 months (range 58 to 212 months).
RESULTS: The mean Harris hip score increased from 27.2 (range 11 to 69) to 79.5 (range 37 to 87) postoperatively. At final follow-ups, all the patients were satisfied with the outcome and were able to walk without support. Three hips (8.1%; 3 patients) required revision. The overall Kaplan-Meier implant survival rate was 86.5%. There were no significant correlations between the Harris hip score and radiographic loosening and the presence of calcification around the prosthesis. Heterotopic bone formation of grade I was observed in 17 hips (46%).
CONCLUSION: Even though it is performed at young ages, THA considerably improves quality of life of patients with JRA having hip joint involvement and has a comparable implant survival.

Entities:  

Mesh:

Year:  2008        PMID: 18552533     DOI: 10.3944/aott.2008.42.2.119

Source DB:  PubMed          Journal:  Acta Orthop Traumatol Turc        ISSN: 1017-995X            Impact factor:   1.511


  8 in total

Review 1.  Has total hip arthroplasty in patients 30 years or younger improved? A systematic review.

Authors:  Muyibat A Adelani; James A Keeney; Allison Palisch; Susan A Fowler; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2013-04-06       Impact factor: 4.176

2.  Evaluation of clinical outcomes of cementless total hip arthroplasty in patients under 30 years of age.

Authors:  Mohsen Mardani-Kivi; Mahmoud Karimi-Mobarakeh; Kamran Asadi; Keyvan Hashemi-Motlagh; Khashayar Saheb-Ekhtiari
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-27

3.  Long Term Outcomes of Total Hip Arthroplasty in Young Patients under 30.

Authors:  Emilios E Pakos; Nikolaos K Paschos; Theodoros A Xenakis
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

4.  Function and fixation of total hip arthroplasty in patients 25 years of age or younger.

Authors:  John C Clohisy; Jeremy M Oryhon; Thorsten M Seyler; Christopher W Wells; Steve S Liu; John J Callaghan; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

Review 5.  Evolution of total hip arthroplasty in patients younger than 30 years of age: A systematic review and meta-analysis.

Authors:  Andrew Konopitski; Chielozor Okafor; Brendan Smith; Keith Baldwin; Neil P Sheth
Journal:  Arch Orthop Trauma Surg       Date:  2022-02-07       Impact factor: 3.067

6.  Staged total hip arthroplasty in a patient with hip dysplasia and a large pertrochanteric bone cyst.

Authors:  Joseph R Langston; Alexander M DeHaan; Thomas W Huff
Journal:  Arthroplast Today       Date:  2016-05-24

7.  Short-term outcomes of one-stage bilateral total hip arthroplasty in young patients (< 30 years old).

Authors:  Afshin Taheriazam; Amin Saeidinia
Journal:  Orthop Rev (Pavia)       Date:  2018-07-04

8.  Outcomes of Unilateral Total Hip Arthroplasty in Patients Aged Under 35 Years in Iranian Population: A Preliminary Study.

Authors:  Mahdi Motififard; Ali Andalib; Seyed Jalil Hamidi; Sajad Badiei
Journal:  Adv Biomed Res       Date:  2018-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.